Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-09-20 | Eliem Therapeutics, Inc. | Pimblett Emily
(CHIEF ACCOUNTING OFFICER) |
S | Common Stock | D | 1191 | $8.06 - $8.18 | $9,740 |
2024-07-19 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 129206 | $7.09 - $8.07 | $988,495 |
2024-07-17 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 41783 | $6.91 - $6.93 | $289,491 |
2024-07-16 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 50000 | $7.13 - $7.13 | $356,500 |
2024-07-12 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 92377 | $7.01 - $7.07 | $650,562 |
2024-07-09 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 105931 | $6.66 - $7.11 | $736,500 |
2024-07-05 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 12342 | $7.06 - $7.06 | $87,134 |
2024-07-03 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
S | Common Stock | D | 50000 | $6.76 - $6.76 | $338,000 |
2024-07-01 | Eliem Therapeutics, Inc. | Morisset Valerie
(EVP, R&D AND CSO) |
M | Common Stock | A | 7649 | $0.00 - $0.00 | $1 |
2024-06-27 | Eliem Therapeutics, Inc. | Shah Rajeev M.
(Director) |
P | Common Stock | A | 13008546 | $3.84 - $3.84 | $49,952,816 |
2024-06-20 | Eliem Therapeutics, Inc. | Pimblett Emily
(CHIEF ACCOUNTING OFFICER) |
S | Common Stock | D | 1245 | $7.21 - $7.21 | $8,982 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |